美股A股
StockGist

Aurora Cannabis Inc.

ACBNASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally.
$4.94-1.00%
报价 2026-11-13
市值
$324.8M
EV
–
PE (TTM)
–
预期 PE
–
52 周区间距高点 -11.3%
$2.58$5.57

筛选结果

pipeline · 2026-11-13
Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool

研究结论

还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。

去生成基本面报告 →

历史股价

加载中…

事件

0 条 · 随区间与图例筛选

该区间内无事件。

同行对比

同行业市值相近 · Drug Manufacturers - Specialty & Generic
公司市值今日预期营收增速毛利率PEEV/EBITDAP/FCF池
ACBAurora Cannabis Inc.$324.8M-1.0%–-5.9%–––
KMDAKamada Ltd.$466.6M-0.5%–42.3%23.3x10.8x–
EOLSEvolus, Inc.$460.7M-3.1%+12.7%65.6%–––
EMBCEmbecta Corp.$366M+0.5%+4.3%59.9%3.3x5.8x1.8xCheap
SNDLSNDL Inc.$335.3M-1.4%–19%–8.8x–
EBSEmergent BioSolutions Inc.$297.7M-1.7%-20.1%49.4%––4.3x
TLRYTilray Brands, Inc.$271.8M-2.4%–30.1%–––
LFCRLifecore Biomedical, Inc.$243.4M+0.3%+62.7%29.7%–––
CGCCanopy Growth Corporation$237.6M-2.2%–27.4%–––
同行中位数––+8.5%36.2%13.3x8.8x3.1x

研究全文

L2 基本面 memo

尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。

财务报表

报告货币 CAD(非美元)
Metric
2026-09-30
Q2 2027
2026-06-30
Q1 2027
2026-03-31
Q4 2026
2025-12-31
Q3 2026
2025-09-30
Q2 2026
2025-06-30
Q1 2026
2025-03-31
Q4 2025
2024-12-31
Q3 2025
RevenueCAD 86MCAD 67.6MCAD 38.1MCAD 94.2MCAD 90.4MCAD 88.2MCAD 90.5MCAD 88.2M
Gross Margin43.6%52.7%47.8%49.5%35.7%89.6%24.2%89.6%
Operating Margin-20.8%-12.9%-66.1%5.1%-20.2%41.8%-33.6%41.8%
Net IncomeCAD -21.1MCAD -4MCAD -57MCAD 1.8MCAD -51.5MCAD 31.7MCAD -24.6MCAD 31.7M
Diluted EPS-0.32-0.07-0.990.03-0.910.57-0.440.58
Operating Cash FlowCAD -14.9MCAD -4.4MCAD -230,000CAD 17MCAD -40.4MCAD 10.1MCAD 3.7MCAD 28.8M

研究材料